United Kingdom· GB-APID-38827511000001105
Rozlytrek 200mg capsules
A entrectinib product containing entrectinib, registered in United Kingdom by Roche Products Ltd. The same ATC class is registered in 14 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Entrectinib is registered in 14 of 19 countries.
Countries holding a registration under ATC L01EX14 (entrectinib), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Entrectinib · ATC L01EX14
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of entrectinib costs, country by country.
Normalised to the WHO defined daily dose (0.6 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Entrectinib · price per daily dose (0.6 g)
USD · FX 28 Sept 2026
- CH Switzerland$216.58
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Entrectinib
- Manufacturer
- Roche Products Ltd
- Country
- United Kingdom (GB)
- ATC code
- L01EX14
- ATC class
- Entrectinib
- Defined daily dose
- 0.6 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin07613326024532
- gtin7613326024532
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
570 interactions on record for entrectinib.
Graded by severity as the source publishes them — 151 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Entrectinib · interactions on record
570 records
- 151 severe
- 405 moderate
- 14 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- AprepitantA04AD12severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Entrectinib in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumRozlytrek 200 mgRoche Registration
- CanadaROZLYTREKHOFFMANN-LA ROCHE LIMITED
- SwitzerlandRozlytrek 200 mg, HartkapselnRoche Pharma (Schweiz) AG
- CzechiaROZLYTREKRoche Registration GmbH, Grenzach-Wyhlen
- SpainROZLYTREK 200 MG CAPSULAS DURASRoche Registration Gmbh
- FinlandRozlytrekRoche Registration GmbH
- IrelandRozlytrek 200 mg hard capsulesRoche Registration GmbH
- IcelandRozlytrekRoche Registration GmbH*
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Rozlytrek
- Liechtenstein · Rozlytrek
- Norway · Rozlytrek
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c484087a-6d0b-4bf1-ae70-ee5e3b8fa3aa GET /v1/drugs/c484087a-6d0b-4bf1-ae70-ee5e3b8fa3aa?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "38827511000001105",
"desc": "Rozlytrek 200mg capsules (Roche Products Ltd)",
"form": "Oral capsule",
"vpid": "38903711000001108",
"source": "dmd",
"vtm_id": "789365000",
"strength": "200 mg",
"substance": "Entrectinib",
"ingredient": "Entrectinib",
"supplier_code": "2085201000001100"
}See everything about entrectinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.